Obstetrical Department, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Clinical Laboratory, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Gynecol Endocrinol. 2020 Sep;36(9):781-785. doi: 10.1080/09513590.2020.1725970. Epub 2020 Feb 14.
Preeclampsia (PE) is a specific obstetric disorder that may result in maternal and neonatal morbidity and mortality. Increasing evidence has been indicated that some candidate genes related to oxidative stress, such as glutamate-cysteine ligase, catalytic subunit (GCLC), glutamate-cysteine ligase, modifier subunit (GCLM), involve in the pathogenesis of PE. After the genetic contribution of GCLC rs17883901 polymorphism was analyzed by TaqMan allelic discrimination real-time PCR in 1001 PE patients and 1182 normal pregnant women, a case-control association analysis was performed. Although no statistical difference was found in genetic distribution of rs17883901 in GCLC between PE and control group ( = 2.201, = .333 by genotypic, = 0.524, = .469, OR = 0.932, 95%CI = 0.771-1.128 by allelic), significant differences in the genotypic frequencies were investigated between mild PE group ( = 6.999, = .030) or late-onset PE group ( = 6.197, = .045) and control group. Furthermore, when dividing the mild PE patients, the late-onset PE patients and the controls into TT/CT + CC, TT + CT/CC, and TT/CC subgroups, we found statistical differences between mild PE and controls (TT/CT + CC: = 5.132, = .023, OR = 2.948, 95%CI = 1.107-7.854; TT/CC: = 4.564, = .033, OR = 2.793, 95%CI = 1.046-7.460) as well as late-onset PE and controls (TT/CT + CC: = 4.043, = .044, OR = 2.248, 95%CI = 1.000-5.055). This is the first study to indicate GCLC rs17883901 polymorphism may be associated with a risk of mild PE and late-onset PE in Chinese Han women. However, additional well-designed studies with multi-ethnic and large-scale samples should be performed to validate our results.
子痫前期(PE)是一种特定的产科疾病,可能导致母婴发病率和死亡率升高。越来越多的证据表明,一些与氧化应激相关的候选基因,如谷氨酸-半胱氨酸连接酶,催化亚基(GCLC)、谷氨酸-半胱氨酸连接酶,调节亚基(GCLM),参与了 PE 的发病机制。在对 1001 例 PE 患者和 1182 例正常孕妇进行 TaqMan 等位基因鉴别实时 PCR 分析 GCLC rs17883901 的遗传贡献后,进行了病例对照关联分析。尽管在 PE 组和对照组之间,GCLC rs17883901 的遗传分布没有统计学差异(基因型 = 2.201, = .333,等位基因 = 0.524, = 0.469,OR = 0.932,95%CI = 0.771-1.128),但在轻度 PE 组( = 6.999, = .030)或晚发型 PE 组( = 6.197, = .045)与对照组之间,基因型频率存在显著差异。此外,当将轻度 PE 患者、晚发型 PE 患者和对照组分为 TT/CT+CC、TT+CT/CC 和 TT/CC 亚组时,我们发现轻度 PE 与对照组之间存在统计学差异(TT/CT+CC: = 5.132, = .023,OR = 2.948,95%CI = 1.107-7.854;TT/CC: = 4.564, = .033,OR = 2.793,95%CI = 1.046-7.460)以及晚发型 PE 与对照组之间(TT/CT+CC: = 4.043, = .044,OR = 2.248,95%CI = 1.000-5.055)。这是第一项表明 GCLC rs17883901 多态性可能与中国汉族妇女轻度 PE 和晚发型 PE 发病风险相关的研究。然而,应该进行更多设计良好的、具有多民族和大规模样本的研究来验证我们的结果。